InvestorsHub Logo
Followers 831
Posts 120032
Boards Moderated 17
Alias Born 09/05/2002

Re: DewDiligence post# 1670

Friday, 11/02/2018 8:14:23 AM

Friday, November 02, 2018 8:14:23 AM

Post# of 3020
ABBV 3Q18 results—HCV sales=$862M (vs ABBV’s $850M guidance):

https://investors.abbvie.com/static-files/184e032f-41e4-4324-a0c9-6683bbef9781

ABBV’s 3Q18 HCV sales were $444M US (+5% QoQ) and $418M ex-US (-24% QoQ). (The $418 ex-US total includes $23M of Viekira sales.)

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENTA News